Biocept (BIOC) Misses Q3 EPS by $0.03

Biocept (NASDAQ: BIOC) reported Q3 EPS of $0.03, $0.03 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.07 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c